Autoimmune and Paraneoplastic Neurological Disorders

[1]  C. Klein,et al.  Striational antibodies in a paraneoplastic context , 2013, Muscle & nerve.

[2]  J. Matsumoto,et al.  Autoimmune chorea in adults , 2013, Neurology.

[3]  C. Klein,et al.  Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. , 2013, JAMA neurology.

[4]  J. Matsumoto,et al.  Adult-onset opsoclonus-myoclonus syndrome. , 2012, Archives of neurology.

[5]  C. Klein,et al.  Chronic pain as a manifestation of potassium channel-complex autoimmunity , 2012, Neurology.

[6]  V. Lennon,et al.  Neural antigen‐specific autoimmune disorders , 2012, Immunological reviews.

[7]  C. Hoogenraad,et al.  Identification of delta/notch‐like epidermal growth factor‐related receptor as the Tr antigen in paraneoplastic cerebellar degeneration , 2012, Annals of neurology.

[8]  R. Buchert,et al.  IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment , 2012, Neurology.

[9]  J. Britton,et al.  Autoimmune epilepsy: clinical characteristics and response to immunotherapy. , 2012, Archives of neurology.

[10]  Jacqueline Palace,et al.  Serologic diagnosis of NMO , 2012, Neurology.

[11]  J. Matsumoto,et al.  Stiff-man syndrome and variants: clinical course, treatments, and outcomes. , 2012, Archives of neurology.

[12]  M. Romero,et al.  Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes , 2011, Proceedings of the National Academy of Sciences.

[13]  R. Balice-Gordon,et al.  Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome , 2011, Neurology.

[14]  J. Parisi,et al.  Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. , 2011, Archives of neurology.

[15]  S. Pittock,et al.  Paraneoplastic encephalomyelopathies: pathology and mechanisms , 2011, Acta Neuropathologica.

[16]  E. Martinez-Hernandez,et al.  Encephalitis and antibodies to synaptic and neuronal cell surface proteins , 2011, Neurology.

[17]  B. Mokri,et al.  Paraneoplastic isolated myelopathy , 2011, Neurology.

[18]  A. Mammen.  Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis , 2011, Nature Reviews Neurology.

[19]  J. Honnorat,et al.  Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience , 2011, Journal of Neurology.

[20]  J. Schott,et al.  Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis , 2011, Annals of neurology.

[21]  R. Balice-Gordon,et al.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis , 2011, The Lancet Neurology.

[22]  C. Wessig,et al.  Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. , 2010, Brain : a journal of neurology.

[23]  J. Britton,et al.  Autoimmune dementia: clinical course and predictors of immunotherapy response. , 2010, Mayo Clinic proceedings.

[24]  J. Parisi,et al.  Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). , 2010, Archives of neurology.

[25]  B. Weinshenker,et al.  Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). , 2010, Brain : a journal of neurology.

[26]  R. Balice-Gordon,et al.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.

[27]  A. Vincent,et al.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[28]  V. Lennon,et al.  Peripherin-IgG association with neurologic and endocrine autoimmunity. , 2010, Journal of autoimmunity.

[29]  V. Lennon,et al.  IMMUNOTHERAPY-RESPONSIVE DEMENTIAS AND ENCEPHALOPATHIES , 2010, Continuum.

[30]  S. Sakoda,et al.  Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. , 2010, Biochemical and biophysical research communications.

[31]  J. Britton,et al.  Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. , 2010, Archives of neurology.

[32]  M. Papadopoulos,et al.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. , 2010, Brain : a journal of neurology.

[33]  D. Friedman,et al.  Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.

[34]  B. Hemmer,et al.  Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica , 2009, Annals of neurology.

[35]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[36]  J. Fak,et al.  Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. , 2009, The Journal of clinical investigation.

[37]  D. Lachance,et al.  Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. , 2009, Archives of neurology.

[38]  B. Volpe,et al.  Losing your nerves? Maybe it's the antibodies , 2009, Nature Reviews Immunology.

[39]  R. Kalb,et al.  AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location , 2009, Annals of neurology.

[40]  C. Lucchinetti,et al.  Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 , 2008, The Journal of experimental medicine.

[41]  Michael K. Hutchinson,et al.  PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY , 2008, Neurology.

[42]  A. Gure,et al.  SOX1 antibodies are markers of paraneoplastic Lambert–Eaton myasthenic syndrome , 2008, Neurology.

[43]  C. Lucchinetti,et al.  Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica , 2007, Neurology.

[44]  Josep Dalmau,et al.  Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.

[45]  E. Benarroch,et al.  Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. , 2006, Mayo Clinic proceedings.

[46]  B. Weinshenker,et al.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. , 2006, Archives of neurology.

[47]  R. Voltz,et al.  The human PNMA family: Novel neuronal proteins implicated in paraneoplastic neurological disease , 2005, Journal of Neuroimmunology.

[48]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[49]  Joseph E Parisi,et al.  Amphiphysin autoimmunity: Paraneoplastic accompaniments , 2005, Annals of neurology.

[50]  V. Lennon,et al.  Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome , 2004, Annals of neurology.

[51]  J. Szurszewski,et al.  Passive Transfer of Autoimmune Autonomic Neuropathy to Mice , 2004, The Journal of Neuroscience.

[52]  M. Rosenfeld,et al.  Clinical analysis of anti-Ma2-associated encephalitis. , 2004, Brain : a journal of neurology.

[53]  P. Tonali,et al.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. , 2003, Brain : a journal of neurology.

[54]  C. Lucchinetti,et al.  Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments , 2003, Annals of neurology.

[55]  J. Szurszewski,et al.  Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. , 2003, The Journal of clinical investigation.

[56]  K. Mills,et al.  Phenotypic variants of autoimmune peripheral nerve hyperexcitability. , 2002, Brain : a journal of neurology.

[57]  C. Adler,et al.  Paraneoplastic chorea associated with CRMP‐5 neuronal antibody and lung carcinoma , 2002, Annals of neurology.

[58]  N. Perrone-Bizzozero,et al.  Role of HuD and other RNA‐binding proteins in neural development and plasticity , 2002, Journal of neuroscience research.

[59]  K. Chan,et al.  ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity , 2001, Annals of neurology.

[60]  A. Vincent,et al.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies , 2001, Nature Medicine.

[61]  E. Benarroch,et al.  CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.

[62]  G. Farrugia,et al.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. , 2000, The New England journal of medicine.

[63]  P. Delves,et al.  The Immune System , 2000 .

[64]  V. Lennon,et al.  New Purkinje cell antibody (PCA‐2): Marker of lung cancer–related neurological autoimmunity , 2000, Annals of neurology.

[65]  Loise M. Francisco,et al.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.

[66]  S. Gultekin,et al.  Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system , 1998, Acta Neuropathologica.

[67]  J. Darnell,et al.  A Post-Transcriptional Regulatory Mechanism Restricts Expression of the Paraneoplastic Cerebellar Degeneration Antigen cdr2 to Immune Privileged Tissues , 1997, The Journal of Neuroscience.

[68]  P. O'Suilleabhain,et al.  Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. , 1995, The New England journal of medicine.

[69]  P. De Camilli,et al.  The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer , 1993, The Journal of experimental medicine.

[70]  B. O'neill,et al.  Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. , 1990, Mayo Clinic proceedings.

[71]  P. De Camilli,et al.  Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. , 1988, The New England journal of medicine.

[72]  L. Elveback,et al.  Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravis a , 1987, Annals of the New York Academy of Sciences.

[73]  J. Lindstrom,et al.  Antibody to acetylcholine receptor in myasthenia gravis , 1976, Neurology.

[74]  J. Trotter,et al.  Cerebellar degeneration with Hodgkin disease. An immunological study. , 1976, Archives of neurology.

[75]  J. Lindstrom,et al.  EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS: CELLULAR AND HUMORAL IMMUNE RESPONSES * , 1976, Annals of the New York Academy of Sciences.

[76]  J. Matsumoto,et al.  Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. , 2013, JAMA neurology.

[77]  S. Gultekin,et al.  Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. , 1999, Brain : a journal of neurology.